1. Home
  2. ERC vs NTHI Comparison

ERC vs NTHI Comparison

Compare ERC & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allspring Multi-Sector Income Fund

ERC

Allspring Multi-Sector Income Fund

N/A

Current Price

$9.01

Market Cap

259.5M

Sector

Finance

ML Signal

N/A

NTHI

NeOnc Technologies Holdings Inc.

N/A

Current Price

$9.60

Market Cap

243.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ERC
NTHI
Founded
2003
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
259.5M
243.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ERC
NTHI
Price
$9.01
$9.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
79.2K
29.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
8.37%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.65
$3.20
52 Week High
$9.78
$16.00

Technical Indicators

Market Signals
Indicator
ERC
NTHI
Relative Strength Index (RSI) 20.91 46.99
Support Level N/A $8.29
Resistance Level $9.45 $10.52
Average True Range (ATR) 0.08 0.60
MACD -0.04 -0.07
Stochastic Oscillator 8.51 20.28

Price Performance

Historical Comparison
ERC
NTHI

About ERC Allspring Multi-Sector Income Fund

Allspring Multi-Sector Income Fund is a closed-end investment management company. The company's core business is to secure a high level of income for its investors consistent with limiting its overall exposure to domestic interest rate risk. It invests in U.S. dollar-denominated below investment-grade bonds, debentures, and other income obligations, including loans and preferred stocks, developed and emerging market debt securities, including obligations of foreign governments or governmental entities, foreign corporations, or supranational agencies denominated in various currencies, asset backed securities and investment grade corporate bonds.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).

Share on Social Networks: